PharmEng Technology

What PharmEng Technology does

PharmEng Technology is a privately held Canadian life-sciences consulting firm founded in 1997 in Toronto by Alan Kwong, providing project-based consulting services to pharmaceutical, biotechnology, medical device, and nutraceutical companies across the full product lifecycle. Core service lines include Commissioning and Qualification, Validation, Quality Services, Regulatory Affairs, Engineering, Project Management, Thermal Mapping, Toxicology, Training, Technical Writing, and Automation Engineering Solutions. The firm employs certified subject matter experts (PMP, ASQ-CQA, Lean Six Sigma, RAC, board-certified toxicologists) and delivers under ISO 9001:2015 ANAB-certified quality management, with validation deliverables described as accepted by FDA and Health Canada.

The business operates on a direct enterprise consulting model with quote-based, multi-year project engagements and a 100% direct-to-client channel. As of January 2025, PharmEng joined the Efor Group, a European life-sciences consulting platform, forming a combined entity of approximately 2,800 employees across 12 countries with €240 million in reported 2024 revenue. The combined firm now operates 14+ offices across Canada, the United States, Singapore, Indonesia, Malaysia, Taiwan, Denmark, Ireland, Spain, Brazil, the Dominican Republic, and Puerto Rico, with named enterprise customers including AbbVie, Alcon, Sanofi, Takeda, and United Therapeutics.

Technology offerings include the proprietary AT-Log Sensing System (launched October 2024), a cloud-based LoRaWAN wireless environmental monitoring platform, and AI/ML capabilities integrated into CQV workflows including predictive maintenance, anomaly detection, and Explainable AI (XAI) methods (SHAP, LIME) for regulatory-grade accountability. Integration partnerships span six MES platforms (Syncade, PAS-X, Aspentech, Pharmasuite, LZ Lifescience, POMSnet), supporting vendor-agnostic automation engineering services for pharmaceutical manufacturing clients.

Name

PharmEng Technology

Legal name

PharmEng Technology

Website

https://pharmeng.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

101–250 employees

Short description

PharmEng Technology is a privately held Canadian life-sciences consulting firm founded in 1997, providing CQV, validation, quality, regulatory affairs, engineering, toxicology, and training services to pharmaceutical, biotechnology, and medical device companies; since January 2025 it operates as part of the Efor Group, serving enterprise clients across 12 countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices15 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Revenue model

1. Pharmaceutical Consulting Services: Professional consulting services provided to pharmaceutical, biotechnology, medical device, and nutraceutical industries. Services include Commissioning & Qualification, Validation, Quality Systems, Regulatory Affairs, Engineering, Training, Toxicology, Thermal Mapping, Technical Writing, Project Management, and Automation Engineering Solutions. Revenue is generated through project-based consulting engagements with subject matter experts.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

PharmEng Technology provides consulting services to pharmaceutical, biotech, and medical device companies. Their service portfolio spans commissioning and qualification, validation, engineering, project management, quality systems, regulatory affairs, thermal mapping, toxicology, training, technical writing, and automation engineering solutions for regulated life-sciences manufacturers.

Product overview

PharmEng Technology is a global full-service consulting firm serving pharmaceutical, biotechnology, medical device, and nutraceutical industries. The company offers an integrated portfolio of consulting services organized around lifecycle stages: from regulatory affairs and pharmaceutical consulting in early development, through engineering and automation for facility/process design, to commissioning & qualification, validation, and quality services for manufacturing compliance. Core service modules include Technical Writing, Toxicology, Thermal Mapping, Project Management, and Training. The AT-Log Sensing System represents a proprietary product offering for environmental monitoring. Services are delivered through over 3,000 experts across 12 countries following the company's 2025 integration with the Efor Group.

Differentiator

Problem solved

Functional benefit

Products and services

• Commissioning and Qualification
• Validation
• Engineering
• Project Management
• Quality Services
• Regulatory Affairs
• Thermal Mapping
• Toxicology
• Training
• Technical Writing
• Automation Engineering Solutions
• AT-Log Sensing System

Named customers7 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability4 records

Feature4 records

Partnerships

One partnership is on record.

• Efor GroupflagshipStrategic or Co-development Partner · 9 January 2025In January 2025, PharmEng Technology joined the Efor Group in a transformative strategic partnership. The Efor Group, founded in 2013, is a European leader in life sciences consulting with over 2,500 employees across France, Belgium, Switzerland, and the United States. The combined entity now operates with 2,800 employees across 12 countries. This partnership enables PharmEng to expand global reach while offering integrated solutions spanning the entire lifecycle of healthcare products from R&D to market launch and post-market vigilance.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Kymanox: US-based life sciences consulting firm providing regulatory affairs, quality, validation, and process engineering services to pharma, biotech, and medical device manufacturers — overlapping service portfolio and target customer base with PharmEng.
• Commissioning Agents Inc (CAI): US-based firm specializing in commissioning, qualification, validation, and regulatory services for pharmaceutical, biotech, and medical device manufacturers — directly comparable to PharmEng's core C&Q/validation business.
• NNE Pharmaplan: Novo Nordisk-owned engineering consultancy specializing in pharma facility design, process engineering, commissioning/qualification, and validation — directly comparable to PharmEng's CQV and engineering services for the same enterprise pharma/biotech buyers.
• Trinity Consultants (ADVENT Engineering division): ADVENT Engineering Services, a Trinity Consultants life sciences division (where PharmEng EVP Dharti Pancholi previously served as COO), provides pharma engineering, validation, and regulatory consulting — directly overlapping with PharmEng's service lines and target market.
• ProPharma Group: Global regulatory, compliance, and quality consulting firm for life sciences companies; offers regulatory affairs, validation, and pharmacovigilance consulting — directly comparable to PharmEng's quality and regulatory service lines.
• Efor Group: PharmEng's parent/strategic partner since January 2025; Efor is a European life sciences consulting firm with 2,800+ employees across 12 countries offering validation, regulatory affairs, quality, and toxicology services — a near-perfect direct peer with overlapping service lines and target customers.
• PharmaLex: Specialist regulatory affairs and pharmacovigilance consulting firm serving pharma and biotech globally; strong overlap with PharmEng's regulatory affairs, quality, and toxicology services and similar enterprise customer profile.

Emerging players

• Atlantic Technical Group: Niche consulting firm providing commissioning, qualification, validation, and metrology services to pharma and biotech manufacturers — a smaller, more specialized peer competing for similar CQV engagements.

Broad incumbents

• ICON plc: Global CRO and consulting services firm serving pharma/biotech; while primarily a clinical CRO, ICON's consulting and bioanalytical labs overlap with parts of PharmEng's quality and validation offerings for large enterprise pharma clients.
• Certara: Large publicly-traded biosimulation and regulatory science consulting firm serving the broader life sciences industry; while Certara is broader and tech-enabled, it competes for the same regulatory affairs and drug development consulting mandates from large pharma.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharmeng-technology
• Xx.com/pharmenginc
• Facebookfacebook.com/pharmengtech

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmEng Technology